The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm ...
Abbott missed analysts' third-quarter revenue estimates on Wednesday, as weakness in its diagnostics and nutrition businesses ...
The global oral clinical nutrition market is expanding, driven by aging populations, rising chronic diseases, and nutrition awareness. Opportunities include tailored formulas for specific diseases, ...
Abbott’s strong Q3, global diversification, and resilient portfolio support long-term growth despite diagnostics softness and ...
The company provides both financial support and volunteer hours to fill the backpacks which selected children receive every ...
Abbott Fund’s $250K donation will help feed 2,000 children through the BackPack Program across nine Illinois counties.
Irish Examiner on MSN
Abbott reports $11.37bn third-quarter revenue
On an adjusted basis, Abbott reported third-quarter profit per share of $1.30, in line with analysts' average estimate. The ...
The fate of hundreds of pending cases against Abbott and Mead Johnson hang in the balance with the latest dismissal.
Abbott Laboratories backed its full-year outlook after posting higher sales in the third quarter, boosted by sales of its nutrition shakes and drinks for adults ...
Continuous glucose monitors — the tiny sensors once reserved for people with diabetes — are now appearing on the arms of ...
Get key Q3 2025 earnings insights for Abbott Labs (ABT)—discover growth drivers, innovation highlights, and outlook for 2026.
Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results